Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
The DOI matches its Crossref record.
Abstract
Since the 1990 NIH-sponsored conference on polycystic ovary syndrome (PCOS), it has become appreciated that the syndrome encompasses a broader spectrum of signs and symptoms of ovarian dysfunction than those defined by the original diagnostic criteria. The 2003 Rotterdam consensus workshop concluded that PCOS is a syndrome of ovarian dysfunction along with the cardinal features hyperandrogenism and polycystic ovary (PCO) morphology. PCOS remains a syndrome and, as such, no single diagnostic criterion (such as hyperandrogenism or PCO) is sufficient for clinical diagnosis. Its clinical manifestations may include: menstrual irregularities, signs of androgen excess, and obesity. Insulin resistance and elevated serum LH levels are also common features in PCOS. PCOS is associated with an increased risk of type 2 diabetes and cardiovascular events.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Diagnosis of PCOS was based on the presence of two out of three Rotterdam Criteria: ovulatory dysfunction presenting as irregular menstrual cycles or amenorrhea, clinical and/or biochemical hyperandrogenism, and ultrasound assessment of polycystic ovaries (≥12 antral follicles in one ovary or ovarian volume ≥ 10 mL) [7,21].”
From Dietary Patterns and Metabolic and Hormonal Parameters in Women with Suspected PCOS (2025) · cites this paper as [7]
In the citing paper
“Moran et al. [126] reported reduced testosterone levels following lifestyle intervention but found no effect on FAI (100 × total testosterone/SHBG), a more valid marker of hyperandrogenism [121].”
From Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis (2019) · cites this paper as [121]
In the citing paper
“The 2023 international evidence-based PCOS guidelines [3] recommend that a PCOS diagnosis should be based on criteria adapted from the Rotterdam criteria [7]; thus, requiring at least two of (1) clinical/biochemical hyperandrogenism; (2) ovulatory dysfunction; and (3) polycystic ovaries on ultrasound (anti-Mullerian hormone can be used instead of ultrasound) [3].”
From Polycystic Ovary Syndrome and the Internet of Things: A Scoping Review (2024) · cites this paper as [7]
In the citing paper
“There is no single diagnostic test, different sets of diagnostic criteria are still used, individual diagnostic criteria lack clarity, and exclusion of other etiologies is needed to establish the diagnosis of PCOS (4, 23, 24).”
From Delayed Diagnosis and a Lack of Information Associated With Dissatisfaction in Women With Polycystic Ovary Syndrome (2016) · cites this paper as [4]
In the citing paper
“There is no single diagnostic test, different sets of diagnostic criteria are still used, individual diagnostic criteria lack clarity, and exclusion of other etiologies is needed to establish the diagnosis of PCOS (4, 23, 24).”
From Delayed Diagnosis and a Lack of Information Associated With Dissatisfaction in Women With Polycystic Ovary Syndrome (2016) · cites this paper as [4]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Still being checked.
Cited by
Items 201–300 of 389
Glueck, C. J., Dharashivkar, S., Wang, P., Zhu, B., Gartside, P. S., Tracy, T., & Sieve, L. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2005.03.010 · Cited by 99
Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis
Sarkar, M., Terrault, N., Chan, W., Cedars, M. I., Huddleston, H. G., Duwaerts, C. C., Balitzer, D., & Gill, R. M. (2020) · Liver International · doi:10.1111/liv.14279 · Cited by 99
Barrea, L., Muscogiuri, G., Pugliese, G., de Alteriis, G., Colao, A., & Savastano, S. (2021) · Nutrients · doi:10.3390/nu13113925 · Cited by 99
“In particular, eligible patients were those with a diagnosis of PCOS classified by the ESHRE/ASRM (European Society for Human Reproduction and Embryology/American Society for Reproductive Medicine) diagnosis [21].”
Backgroundde Melo, A. S., Dias, S. V., Cavalli, R. D. C., Cardoso, V. C., Bettiol, H., Barbieri, M. A., Ferriani, R. A., & Vieira, C. S. (2015) · Reproduction · doi:10.1530/rep-14-0499 · Cited by 99
Facchinetti, F., Orrù, B., Grandi, G., & Unfer, V. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1540578 · Cited by 94
Fruzzetti, F., Perini, D., Lazzarini, V., Parrini, D., & Genazzani, A. R. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.004 · Cited by 95
PCOS Physiopathology and Vitamin D Deficiency: Biological Insights and Perspectives for Treatment
Morgante, G., Darino, I., Spanò, A., Luisi, S., Luddi, A., Piomboni, P., Governini, L., & De Leo, V. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154509 · Cited by 95
Reproduction in females: The role of the early life environment
Sloboda, D. M., Hickey, M., & Hart, R. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq048 · Cited by 94
Polycystic ovaries and ovarian hyperstimulation syndrome: a systematic review*
Tummon, I., Gavrilova‐Jordan, L., Allemand, M. C., & Session, D. (2005) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/j.0001-6349.2005.00788.x · Cited by 94
Fraison, E., Kostova, E., Moran, L. J., Bilal, S., Ee, C. C., Venetis, C., & Costello, M. F. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005552.pub3 · Cited by 94
Panidis, D., Tziomalos, K., Papadakis, E., Vosnakis, C., Chatzis, P., & Katsikis, I. (2013) · Endocrine · doi:10.1007/s12020-013-9971-5 · Cited by 93
Endometriosis and polycystic ovary syndrome are diametric disorders
Dinsdale, N. L., & Crespi, B. J. (2021) · Evolutionary Applications · doi:10.1111/eva.13244 · Cited by 90
Barrera, F. J., Brown, E. D. L., Rojo, A., Obeso, J., Plata, H., Lincango, E. P., Terry, N., Rodríguez-Gutiérrez, R., Hall, J. E., & Shekhar, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1106625 · Cited by 91
Association between circadian rhythm disruption and polycystic ovary syndrome
Wang, F., Xie, N., Wu, Y., Zhang, Q., Zhu, Y., Dai, M., Zhou, J., Pan, J., Tang, M., Cheng, Q., et al. (2021) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.08.1425 · Cited by 91
Pizzo, A., Laganà, A. S., & Barbaro, L. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2013.860120 · Cited by 90
PCOS and nutritional approaches: Differences between lean and obese phenotype
Barrea, L., Frias-Toral, E., Verde, L., Ceriani, F., Cucalón, G., Garcia-Velasquez, E., Moretti, D., Savastano, S., Colao, A., & Muscogiuri, G. (2021) · Metabolism Open · doi:10.1016/j.metop.2021.100123 · Cited by 86
Allaway, H. C. M., Southmayd, E. A., & De Souza, M. J. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0053 · Cited by 89
Kazemi, M., Kim, J. Y., Wan, C., Xiong, J. D., Michalak, J., Xavier, I. B., Ganga, K., Tay, C. T., Grieger, J. A., Parry, S. A., et al. (2022) · Human Reproduction Update · doi:10.1093/humupd/dmac023 · Cited by 89
Coyle, C., & Campbell, R. E. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110561 · Cited by 89
Prevalence and risk of depressive disorders in women with polycystic ovary syndrome (PCOS)
Bhattacharya, S. M., & Jha, A. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.09.025 · Cited by 88
Insulin Resistance is Associated with Depression Risk in Polycystic Ovary Syndrome
Greenwood, E. A., Pasch, L. A., Cedars, M. I., Legro, R. S., Eisenberg, E., & Huddleston, H. G. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.03.009 · Cited by 88
Melatonin Treatment May Be Able to Restore Menstrual Cyclicity in Women With PCOS: A Pilot Study
Tagliaferri, V., Romualdi, D., Scarinci, E., De Cicco, S., Di Florio, C., Immediata, V., Tropea, A., Santarsiero, C. M., Lanzone, A., & Apa, R. (2018) · Reproductive Sciences · doi:10.1177/1933719117711262 · Cited by 87
Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS?
Muscogiuri, G., Policola, C., Prioletta, A., Sorice, G., Mezza, T., Lassandro, A., Della Casa, S., Pontecorvi, A., & Giaccari, A. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2011.12.010 · Cited by 86
Children's Hospital Association Consensus Statements for Comorbidities of Childhood Obesity
Estrada, E., Eneli, I., Hampl, S., Mietus-Snyder, M., Mirza, N., Rhodes, E., Sweeney, B., Tinajero-Deck, L., Woolford, S. J., & Pont, S. J. (2014) · Childhood Obesity · doi:10.1089/chi.2013.0120 · Cited by 85
Effect of weight loss on menstrual function in adolescents with polycystic ovary syndrome
Ornstein, R. M., Copperman, N. M., & Jacobson, M. S. (2011) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2011.01.002 · Cited by 82
PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis
Millán-de-Meer, M., Luque-Ramírez, M., Nattero-Chávez, L., & Escobar-Morreale, H. F. (2023) · Human Reproduction Update · doi:10.1093/humupd/dmad015 · Cited by 82
Jakubowicz, D., Barnea, M., Wainstein, J., & Froy, O. (2013) · Clinical Science · doi:10.1042/cs20130071 · Cited by 81
Xing, C., Zhao, H., Zhang, J., & He, B. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.945609 · Cited by 82
Teede, H., Tassone, E. C., Piltonen, T., Malhotra, J., Mol, B. W., Peña, A., Witchel, S. F., Joham, A., McAllister, V., Romualdi, D., et al. (2019) · Clinical Endocrinology · doi:10.1111/cen.14013 · Cited by 79
Jiskoot, G., Dietz de Loos, A., Beerthuizen, A., Timman, R., Busschbach, J., & Laven, J. (2020) · PLOS ONE · doi:10.1371/journal.pone.0233876 · Cited by 76
Yilmaz, M., Biri, A., Karakoç, A., Törüner, F., Bingöl, B., Çakir, N., Tiras, B., Ayvaz, G., & Arslan, M. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03345339 · Cited by 77
Machine-aided self-diagnostic prediction models for polycystic ovary syndrome: observational study
Zigarelli, A., Jia, Z., & Lee, H. (2022) · JMIR Formative Research · doi:10.2196/29967 · Cited by 74
Marti, N., Galván, J. A., Pandey, A. V., Trippel, M., Tapia, C., Müller, M., Perren, A., & Flück, C. E. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.07.029 · Cited by 76
Kuchenbecker, W. K. H., Groen, H., van Asselt, S. J., Bolster, J. H. T., Zwerver, J., Slart, R. H. J., vd Jagt, E. J., Muller Kobold, A. C., Wolffenbuttel, B. H. R., Land, J. A., et al. (2011) · Human Reproduction · doi:10.1093/humrep/der229 · Cited by 76
Gambineri, A., Vicennati, V., Genghini, S., Tomassoni, F., Pagotto, U., Pasquali, R., & Walker, B. R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2222 · Cited by 75
Günalan, E., Yaba, A., & Yılmaz, B. (2018) · Journal of the Turkish-German Gynecological Association · doi:10.4274/jtgga.2018.0077 · Cited by 74
Kahal, H., Aburima, A., Ungvari, T., Rigby, A. S., Coady, A. M., Vince, R. V., Ajjan, R. A., Kilpatrick, E. S., Naseem, K. M., & Atkin, S. L. (2015) · BMC Endocrine Disorders · doi:10.1186/s12902-015-0005-6 · Cited by 74
A reappraisal of the role of polycystic ovary syndrome in recurrent miscarriage
Cocksedge, K. A., Li, T.-C., Saravelos, S. H., & Metwally, M. (2008) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60304-5 · Cited by 73
Lerchbaum, E., Schwetz, V., Giuliani, A., & Obermayer-Pietsch, B. (2013) · Human Reproduction · doi:10.1093/humrep/det255 · Cited by 73
Effects of vitamin D supplementation in women with polycystic ovary syndrome: a review
Menichini, D., & Facchinetti, F. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1625881 · Cited by 73
Melin, J., Forslund, M., Alesi, S., Piltonen, T., Romualdi, D., Spritzer, P. M., Tay, C. T., Pena, A., Witchel, S. F., Mousa, A., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad098 · Cited by 72
The Polycystic Ovary Syndrome and recent human evolution
Corbett, S., & Morin-Papunen, L. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.01.001 · Cited by 68
Palomba, S., Falbo, A., Chiossi, G., Muscogiuri, G., Fornaciari, E., Orio, F., Tolino, A., Colao, A., La Sala, G. B., & Zullo, F. (2014) · Steroids · doi:10.1016/j.steroids.2014.06.005 · Cited by 69
Fiers, T., Wu, F., Moghetti, P., Vanderschueren, D., Lapauw, B., & Kaufman, J.-M. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02360 · Cited by 70
Ismayilova, M., & Yaya, S. (2022) · BMC Women's Health · doi:10.1186/s12905-022-01630-3 · Cited by 68
Austregésilo de Athayde De Hollanda Morais, B., Martins Prizão, V., de Moura de Souza, M., Ximenes Mendes, B., Rodrigues Defante, M. L., Cosendey Martins, O., & Rodrigues, A. M. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108834 · Cited by 68
Forslund, M., Landin-Wilhelmsen, K., Trimpou, P., Schmidt, J., Brännström, M., & Dahlgren, E. (2020) · Human Reproduction Open · doi:10.1093/hropen/hoz042 · Cited by 66
Tomlinson, J., Millward, A., Stenhouse, E., & Pinkney, J. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.02994.x · Cited by 66
Kurzthaler, D., Hadziomerovic-Pekic, D., Wildt, L., & Seeber, B. E. (2014) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-12-98 · Cited by 66
Clustering of PCOS-like traits in naturally hyperandrogenic female rhesus monkeys
Abbott, D. H., Rayome, B. H., Dumesic, D. A., Lewis, K. C., Edwards, A. K., Wallen, K., Wilson, M. E., Appt, S. E., & Levine, J. E. (2017) · Human Reproduction · doi:10.1093/humrep/dex036 · Cited by 66
Glueck, C. J., Morrison, J. A., Friedman, L. A., Goldenberg, N., Stroop, D. M., & Wang, P. (2006) · Metabolism · doi:10.1016/j.metabol.2005.11.003 · Cited by 65
Corbett, S. J., McMichael, A. J., & Prentice, A. M. (2009) · American Journal of Human Biology · doi:10.1002/ajhb.20937 · Cited by 64
Cardiometabolic Risk in PCOS: More than a Reproductive Disorder
Torchen, L. C. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0956-2 · Cited by 65
Interventions for hirsutism (excluding laser and photoepilation therapy alone)
van Zuuren, E. J., Fedorowicz, Z., Carter, B., & Pandis, N. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010334.pub2 · Cited by 65
Gustafson, E., Pacheco, J., Wehbe, F., Silverberg, J., & Thompson, W. (2017) · 2017 IEEE International Conference on Healthcare Informatics (ICHI) · doi:10.1109/ichi.2017.31 · Cited by 65
The clinical and biochemical significance of 11-oxygenated androgens in human health and disease
Storbeck, K.-H., & O’Reilly, M. W. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad047 · Cited by 63
Graff, S. K., Mario, F. M., Ziegelmann, P., & Spritzer, P. M. (2016) · International Journal of Clinical Practice · doi:10.1111/ijcp.12787 · Cited by 63
Luque-Ramírez, M., Nattero-Chávez, L., Ortiz Flores, A. E., & Escobar-Morreale, H. F. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmx039 · Cited by 62
Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS)
Barrea, L., Verde, L., Camajani, E., Cernea, S., Frias-Toral, E., Lamabadusuriya, D., Ceriani, F., Savastano, S., Colao, A., & Muscogiuri, G. (2023) · Current Nutrition Reports · doi:10.1007/s13668-023-00456-1 · Cited by 62
Basu, B., Chowdhury, O., & Saha, S. (2018) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_78_17 · Cited by 61
Thomson, R. L., Buckley, J. D., & Brinkworth, G. D. (2016) · BMC Women's Health · doi:10.1186/s12905-016-0292-8 · Cited by 60
Forslund, M., Landin‐Wilhelmsen, K., Schmidt, J., Brännström, M., Trimpou, P., & Dahlgren, E. (2019) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13489 · Cited by 60
Metformin versus lifestyle changes in treating women with polycystic ovary syndrome
Curi, D. D. G., Fonseca, A. M., Marcondes, J. A. M., Almeida, J. A. M., Bagnoli, V. R., Soares, J. M., & Baracat, E. C. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2011.583957 · Cited by 60
Increased plasma metastin levels in adolescent women with polycystic ovary syndrome
Chen, X., Mo, Y., Li, L., Chen, Y., Li, Y., & Yang, D. (2010) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2009.11.018 · Cited by 60
Matteo, M., Serviddio, G., Massenzio, F., Scillitani, G., Castellana, L., Picca, G., Sanguedolce, F., Cignarelli, M., Altomare, E., Bufo, P., et al. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.01.049 · Cited by 59
Naltrexone treatment in clomiphene resistant women with polycystic ovary syndrome
Ahmed, M. I., Duleba, A. J., El Shahat, O., Ibrahim, M. E., & Salem, A. (2008) · Human Reproduction · doi:10.1093/humrep/den273 · Cited by 58
Moran, L. J., Noakes, M., Clifton, P., Buckley, J., Brinkworth, G., Thomson, R., & Norman, R. J. (2019) · Nutrients · doi:10.3390/nu11030492 · Cited by 57
Romualdi, D., Giuliani, M., Cristello, F., Fulghesu, A. M., Selvaggi, L., Lanzone, A., & Guido, M. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.01.114 · Cited by 58
Hadjiconstantinou, M., Mani, H., Patel, N., Levy, M., Davies, M., Khunti, K., & Stone, M. (2017) · Endocrine Connections · doi:10.1530/ec-17-0053 · Cited by 55
High-fat high-sugar diet induces polycystic ovary syndrome in a rodent model†
Roberts, J. S., Perets, R. A., Sarfert, K. S., Bowman, J. J., Ozark, P. A., Whitworth, G. B., Blythe, S. N., & Toporikova, N. (2017) · Biology of Reproduction · doi:10.1095/biolreprod.116.142786 · Cited by 58
Hyperinsulinaemic androgen excess in adolescent girls
Ibáñez, L., Ong, K. K., López-Bermejo, A., Dunger, D. B., & de Zegher, F. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.58 · Cited by 56
Mizgier, M., Jarząbek-Bielecka, G., Wendland, N., Jodłowska-Siewert, E., Nowicki, M., Brożek, A., Kędzia, W., Formanowicz, D., & Opydo-Szymaczek, J. (2021) · Nutrients · doi:10.3390/nu13030896 · Cited by 56
Brown, M., Park, A. S., Shayya, R. F., Wolfson, T., Su, H. I., & Chang, R. J. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23992 · Cited by 54
Colwell, K., Lujan, M. E., Lawson, K. L., Pierson, R. A., & Chizen, D. R. (2010) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)34499-1 · Cited by 51
Du, Q., Wang, Y.-J., Yang, S., Wu, B., Han, P., & Zhao, Y.-Y. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.681636 · Cited by 53
Wu, J., Zhu, Y., Jiang, Y., & Cao, Y. (2008) · Gynecological Endocrinology · doi:10.1080/09513590802217027 · Cited by 52
López, E., Joanne, G., Daya, S., Daya, S., Parrilla, J. J., Abad, L., Balasch, J., & Balasch, J. (2004) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)61273-4 · Cited by 52
Ramezani Tehrani, F., Minooee, S., & Azizi, F. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0094 · Cited by 51
Identification of subjects with polycystic ovary syndrome using electronic health records
Castro, V., Shen, Y., Yu, S., Finan, S., Pau, C. T., Gainer, V., Keefe, C. C., Savova, G., Murphy, S. N., Cai, T., et al. (2015) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-015-0115-z · Cited by 51
Feng, L., Lin, X.-F., Wan, Z.-H., Hu, D., & Du, Y.-K. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1041906 · Cited by 50
Jiskoot, G., Benneheij, S. H., Beerthuizen, A., de Niet, J. E., de Klerk, C., Timman, R., Busschbach, J. J., & Laven, J. S. E. (2017) · Reproductive Health · doi:10.1186/s12978-017-0295-4 · Cited by 50
Tiwari, N., Pasrija, S., & Jain, S. (2019) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2018.12.021 · Cited by 50
Arikan, S., Akay, H., Bahceci, M., Tuzcu, A., & Gokalp, D. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.11.057 · Cited by 49
Moran, L., Grieger, J., Mishra, G., & Teede, H. (2015) · Nutrients · doi:10.3390/nu7105419 · Cited by 49
Lujan, M. E., Bloski, T. G., Chizen, D. R., Lehotay, D. C., & Pierson, R. A. (2010) · Human Reproduction · doi:10.1093/humrep/dep363 · Cited by 49
Salvesen, K. Å., Vanky, E., & Carlsen, S. M. (2007) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.3965 · Cited by 48
Polak, A. M., Adamska, A., Krentowska, A., Łebkowska, A., Hryniewicka, J., Adamski, M., & Kowalska, I. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030732 · Cited by 48
Zhao, F., Wu, L., Wang, Q., Zhao, X., Chen, T., Yin, C., Yan, L., & Yang, X. (2022) · Cell Proliferation · doi:10.1111/cpr.13216 · Cited by 48
Hurd, W. W., Abdel-Rahman, M. Y., Ismail, S. A., Abdellah, M. A., Schmotzer, C. L., & Sood, A. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.07.002 · Cited by 46
Armanini, D., Bordin, L., Donà, G., Sabbadin, C., Bakdounes, L., Ragazzi, E., Giorgino, F. L., & Fiore, C. (2012) · Steroids · doi:10.1016/j.steroids.2012.02.010 · Cited by 45
Early ovarian ageing: are women with polycystic ovaries protected?
Nikolaou, D., & Gilling-Smith, C. (2004) · Human Reproduction · doi:10.1093/humrep/deh419 · Cited by 46
Bhattacharya, K., Sengupta, P., Dutta, S., Chaudhuri, P., Das Mukhopadhyay, L., & Syamal, A. K. (2021) · Endocrine · doi:10.1007/s12020-020-02555-3 · Cited by 45
Bayona, A., Martínez-Vaello, V., Zamora, J., Nattero-Chávez, L., Luque-Ramírez, M., & Escobar-Morreale, H. F. (2022) · Human Reproduction Update · doi:10.1093/humupd/dmac011 · Cited by 44
Kanamarlapudi, V., Gordon, U. D., & López Bernal, A. (2016) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2016.03.003 · Cited by 44
Panidis, D., Tziomalos, K., Papadakis, E., Chatzis, P., Kandaraki, E. A., Tsourdi, E. A., & Katsikis, I. (2014) · Clinical Endocrinology · doi:10.1111/cen.12305 · Cited by 43
Jabbour, R., Ott, J., Eppel, W., & Frigo, P. (2020) · PLOS ONE · doi:10.1371/journal.pone.0232299 · Cited by 43
Ovarian and extra-ovarian mediators in the development of polycystic ovary syndrome
Puttabyatappa, M., & Padmanabhan, V. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0079 · Cited by 43
Wang, X., Xu, T., Liu, R., Wu, G., Gu, L., Zhang, Y., Zhang, F., Fu, H., Ling, Y., Wei, X., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.806331 · Cited by 42
Diabetes risk score in the diagnostic categories of polycystic ovary syndrome
Moran, L. J., Strauss, B. J., & Teede, H. J. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.01.133 · Cited by 41
Pinola, P., Morin-Papunen, L. C., Bloigu, A., Puukka, K., Ruokonen, A., Jarvelin, M. R., Franks, S., Tapanainen, J. S., & Lashen, H. (2014) · Human Reproduction · doi:10.1093/humrep/deu182 · Cited by 41
Metadata
- Authors
- The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group
- Corresponding author
- The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-01-01
- Volume
- 19
- Issue
- 1
- Pages
- 41-47
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W4256605237
- Cited by
- 6,138
- References
- 0
- Citations by year
- 2026: 346 · 2025: 412 · 2024: 472 · 2023: 434 · 2022: 419 · 2021: 395 · 2020: 342 · 2019: 326 · 2018: 263 · 2017: 265 · 2016: 226 · 2015: 259 · 2014: 266 · 2013: 249 · 2012: 232
- FWCI
- 76.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Keywords
- polycystic ovary syndrome, diagnostic criteria, hyperandrogenism, polycystic ovary morphology, ovarian dysfunction, menstrual irregularity, insulin resistance, luteinizing hormone, type 2 diabetes risk, cardiovascular risk, obesity
- MeSH terms
- Clinical Trials as Topic, Consensus Statements as Topic, Female, Humans, Insulin Resistance, Luteinizing Hormone, Polycystic Ovary Syndrome, Risk Factors, United States, Consensus Development Conferences, NIH as Topic, Hyperandrogenism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.